Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Completed 4Active not recruiting 2Withdrawn 1Recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Prostatic Neoplasms 9Uterine Cervical Neoplasms 5Vaginal Neoplasms 2Radiation Injuries 2Endometrial Neoplasms 2Breast Neoplasms 2Sarcoma 1Rhabdomyosarcoma 1Retinoblastoma 1Prostatic Diseases 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neuroectodermal Tumors, Primitive, Peripheral 1Metastatic Malignant Female Reproductive System Neoplasm 1Gynecologic Cancer 1Desmoplastic Small Round Cell Tumor 1Carcinosarcoma 1Carcinoma, Ductal 1

Interventions

Radiotherapy 2Brachytherapy 2entinostat 1bintrafusp alfa protein, human 1Vaccines 1Surveys and Questionnaires 1Radiotherapy, Intensity-Modulated 1Radiation 1Platinum 1Papillomavirus Vaccines 1Magnetic Resonance Spectroscopy 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Congresses as Topic 1Cisplatin 13-aminopyridine-2-carboxaldehyde thiosemicarbazone 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Vaginal Neoplasms × Brachytherapy × Clear all
NCT02466971 2026-06-15

Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers

National Cancer Institute (NCI)

Phase 3 Active not recruiting
450 enrolled 11 charts
Gynecologic

Uterine Cervical Neoplasms, Vaginal Neoplasms

NCT03634267 2026-04-15

MRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA Vaginal Cancer

M.D. Anderson Cancer Center

Phase 1 Active not recruiting
26 enrolled
Gynecologic

Uterine Cervical Neoplasms, Vaginal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡